References
- Aarons, C.B., et al., 2007. Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity. Annals of surgery, 245 (2), 176.
- Aguilar, M., et al., 2015. Prevalence of the metabolic syndrome in the United States, 2003–2012. JAMA, 313 (19), 1973–1974.
- Ando, K., and Fujita, T., 2009. Metabolic syndrome and oxidative stress. Free radical biology & medicine, 47 (3), 213–218.
- Arjmand, M.H., et al., 2020. Intraperitoneal administration of telmisartan prevents postsurgical adhesion band formation. The journal of surgical research, 248, 171–181.
- Braun, K. M., and Diamond, M. P., 2014. The biology of adhesion formation in the peritoneal cavity. Paper presented at the Seminars in pediatric surgery.
- Buckman, R.F., et al., 1976. A physiologic basis for the adhesion-free healing of deperitonealized surfaces. The journal of surgical research, 21 (2), 67–76.
- Chang, S.C., and Yang, W.V., 2016. Hyperglycemia, tumorigenesis, and chronic inflammation. Critical reviews in oncology/hematology, 108, 146–153.
- Chegini, N., et al., 2001. Differential expression of TGF-beta1 and TGF-beta3 in serosal tissues of human intraperitoneal organs and peritoneal adhesions. Human reproduction, 16 (6), 1291–1300.
- Cheng, X., et al., 2013. Both ERK/MAPK and TGF-Beta/Smad signaling pathways play a role in the kidney fibrosis of diabetic mice accelerated by blood glucose fluctuation. Journal of diabetes research, 2013, 463740.
- Chung, S.S., et al., 2003. Contribution of polyol pathway to diabetes-induced oxidative stress. Journal of the american society of nephrology, 14 (8 Suppl 3), S233–S236.
- Cigolini, M., et al., 1996. Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men. Arteriosclerosis, thrombosis, and vascular biology, 16 (3), 368–374.
- Cosman, F., et al., 2005. Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature. Thrombosis research, 116 (1), 1–13.
- Després, J.P., 2006. Is visceral obesity the cause of the metabolic syndrome? Annals of medicine, 38 (1), 52–63.
- Dinarvand, P., et al., 2013. Novel approach to reduce postsurgical adhesions to a minimum: administration of losartan plus atorvastatin intraperitoneally. Journal of surgical research, 181 (1), 91–98.
- diZerega, G.S., and Campeau, J.D., 2001. Peritoneal repair and post-surgical adhesion formation. Human reproduction update, 7 (6), 547–555.
- Esteve, E., Ricart, W., and Fernández-Real, J.M., 2005. Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clinical nutrition, 24 (1), 16–31.
- Ford, E.S., 2003. The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis, 168 (2), 351–358.
- Fortin, C.N., Saed, G.M., and Diamond, M.P., 2015. Predisposing factors to post-operative adhesion development. Human reproduction update, 21 (4), 536–551.
- Frühbeck, G., et al., 2001. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. American journal of physiology. Endocrinology and metabolism, 280 (6), E827–847.
- Godsland, I.F., et al., 2005. Hemostatic risk factors and insulin sensitivity, regional body fat distribution, and the metabolic syndrome. The journal of clinical endocrinology & metabolism, 90 (1), 190–197.
- Guimarães, E.L., et al., 2010. Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells. Journal of hepatology, 52 (3), 389–397.
- Holmdahl, L., et al., 1996. Fibrinolysis in human peritoneum during operation. Surgery, 119 (6), 701–705.
- Honjo, K., et al., 2017. Plasminogen activator inhibitor-1 regulates macrophage-dependent postoperative adhesion by enhancing EGF-HER1 signaling in mice. FASEB journal: official publication of the federation of american societies for experimental biology, 31 (6), 2625–2637.
- Hotamisligil, G.S., et al., 1995. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. Journal of clinical investigation, 95 (5), 2409–2415.
- Ivarsson, M.L., et al., 1998. Tissue markers as predictors of postoperative adhesions. The British journal of surgery, 85 (11), 1549–1554.
- Jarvis, G.E., et al., 2002. Distinct roles of GPVI and integrin alpha(2)beta(1) in platelet shape change and aggregation induced by different collagens. British journal of pharmacology, 137 (1), 107–117.
- Juhan-Vague, I., Alessi, M., and Vague, P., 1991. Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis. Diabetologia, 34 (7), 457–462.
- Kim, H., et al., 2017. Survival benefit of liver resection for Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma. British journal of surgery, 104 (8), 1045–1052.
- Kop, W.J., et al., 2002. Inflammation and coagulation factors in persons> 65 years of age with symptoms of depression but without evidence of myocardial ischemia. The American journal of cardiology, 89 (4), 419–424.
- Lalountas, M., et al., 2012. Postoperative adhesion prevention using a statin-containing cellulose film in an experimental model. British journal of surgery, 99 (3), 423–429.
- Landin, K., et al., 1990. Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism: clinical and experimental, 39 (10), 1044–1048.
- Liu, Y., Fiskum, G., and Schubert, D., 2002. Generation of reactive oxygen species by the mitochondrial electron transport chain. Journal of neurochemistry, 80 (5), 780–787.
- Lundorff, P., et al., 2015. Predicting formation of adhesions after gynaecological surgery: development of a risk score. Archives of gynecology and obstetrics, 292 (4), 931–938.
- Matsuda, M., and Shimomura, I., 2013. Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer. Obesity research & clinical practice, 7 (5), e330–e341.
- Mavri, A., Alessi, M.C., and Juhan-Vague, I., 2004. Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseases. Journal of internal medicine, 255 (4), 448–456.
- Meigs, J.B., et al., 2000. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the framingham offspring study. JAMA, 283 (2), 221–228.
- Mertens, I., and Van Gaal, L.F., 2002. Obesity, haemostasis and the fibrinolytic system. Obesity reviews: an official journal of the international association for the study of obesity, 3 (2), 85–101.
- Molinas, C.R., and Koninckx, P.R., 2000. Hypoxaemia induced by CO(2) or helium pneumoperitoneum is a co-factor in adhesion formation in rabbits. Human reproduction, 15 (8), 1758–1763.
- Monteiro, R., and Azevedo, I., 2010. Chronic inflammation in obesity and the metabolic syndrome. Mediators of inflammation, 2010, 1–10.
- Oladejo, A., 2011. Overview of the metabolic syndrome; an emerging pandemic of public health significance. Annals of ibadan postgraduate medicine, 9 (2), 78–82.
- Pannacciulli, N., et al., 2001. C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women. International journal of obesity and related metabolic disorders: journal of the international association for the study of obesity, 25 (10), 1416–1420.
- Pinkhasov, B., et al., 2012. Age dependence of metabolic syndrome association with obesity types among women. Advances in gerontology = Uspekhi Gerontologii, 25 (4), 617–622.
- Pittas, A.G., Joseph, N.A., and Greenberg, A.S., 2004. Adipocytokines and insulin resistance. The journal of clinical endocrinology and metabolism, 89 (2), 447–452.
- Ramos-Levi, A.M., et al., 2013. Remission of type 2 diabetes mellitus should not be the foremost goal after bariatric surgery. Obesity surgery, 23 (12), 2020–2025.
- Raynaud, E., et al., 2000. Relationships between fibrinogen and insulin resistance. Atherosclerosis, 150 (2), 365–370.
- Rizk, N.N., Saed, G.M., and Diamond, M.P., 2006. Effects of hyperglycemia on the differential expression of insulin and insulin-like growth factor-I receptors in human normal peritoneal and adhesion fibroblasts. Fertility and sterility, 86 (4), 1217–1222.
- Rudich, A., Kanety, H., and Bashan, N., 2007. Adipose stress-sensing kinases: linking obesity to malfunction. Trends in endocrinology and metabolism, 18 (8), 291–299.
- Saed, G.M., and Diamond, M.P., 2004. Molecular characterization of postoperative adhesions: the adhesion phenotype. The journal of the American association of gynecologic laparoscopists, 11 (3), 307–314.
- Saed, G.M., et al., 1999. Alteration of type I and III collagen expression in human peritoneal mesothelial cells in response to hypoxia and transforming growth factor-beta1. Wound repair and regeneration: official publication of the wound healing society [and] the European tissue repair society, 7 (6), 504–510.
- Samad, F., et al., 2000. Insulin continues to induce plasminogen activator inhibitor 1 gene expression in insulin-resistant mice and adipocytes. Molecular medicine, 6 (8), 680–692.
- Sulaiman, H., et al., 2002. Role of plasminogen activators in peritoneal adhesion formation. Biochemical society transactions, 30 (2), 126–131.
- Tan, C.K., et al., 2012. Getting ‘Smad’ about obesity and diabetes. Nutrition & diabetes, 2 (3), e29.
- Van Goor, H., 2007. Consequences and complications of peritoneal adhesions. Colorectal disease, 9 (s2), 25–34.
- Xu, H., et al., 2003. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Journal of clinical investigation, 112 (12), 1821–1830.
- Yarnell, J.W., et al., 2000. Lifestyle and hemostatic risk factors for ischemic heart disease: the Caerphilly Study. Arteriosclerosis, thrombosis, and vascular biology, 20 (1), 271–279.
- Yudkin, J.S., et al., 1999. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arteriosclerosis, thrombosis, and vascular biology, 19 (4), 972–978.